Daniela Pugliese

Plain English
This study examined the differences between men and women regarding complications during and after a procedure called transvenous lead extraction (TLE), which is used to remove wires from heart devices. Researchers looked at data from nearly 21,000 patients and found that while men and women had similar rates of in-hospital deaths (about 1.12 times the risk for women), women faced a higher risk of heart complications (1.24 times greater) and lung issues (1.21 times greater). These findings are important because they suggest that women may need different attention and safety plans during TLE to prevent complications. Who this helps: This helps doctors and healthcare providers in treating patients with cardiac devices.

Plain English
This study looked at how well patients with osteoporosis were treated over 20 years in a specialized osteoporosis clinic compared to general doctors and other specialty clinics. It found that patients in the osteoporosis clinic received treatment rates of 70.2% over three years and 60.2% over five years, which were significantly higher than the 56.1% and 48.5% rates seen in primary care settings. This is important because it highlights the benefit of focused care for osteoporosis, which can lead to better treatment rates and outcomes for patients. Who this helps: Patients with osteoporosis gain better access to effective treatments.

Plain English
This study looked at how to better manage ulcerative colitis (UC), a long-lasting digestive disease that can worsen over time. The researchers found that nearly 50% of UC patients are not getting enough relief from their symptoms and treatments, meaning many still show signs of inflammation and poor quality of life. This is important because achieving better disease control can lead to fewer complications and improved long-term health outcomes for patients. Who this helps: This helps patients with ulcerative colitis and their doctors in managing the disease more effectively.

Plain English
Researchers studied a special type of glass (GeSbSNa) to see how it responds when hit with very fast laser pulses, which can change the glass's properties. They found that the glass could change its refractive index significantly, with changes as high as 62 radians and a refractive index contrast over 0.05, making it one of the best-performing materials in its category. This is important because it means this glass could be used in making advanced infrared optical devices that require precise and stable performance. Who this helps: This helps engineers and developers working on optical devices for medical imaging or telecommunications.

Plain English
This study looked at how well three treatments—vedolizumab, ustekinumab, and Janus kinase inhibitors (JAKis)—work for patients with ulcerative colitis who had not responded to another treatment called anti-TNF-α. Researchers found that ustekinumab and JAKis led to higher rates of remission after 12 months compared to vedolizumab, with ustekinumab showing 54% better chances for clinical remission and JAKis showing 66% better chances. However, JAKis also had a much higher risk of side effects, about four times more than the other treatments. Who this helps: This information benefits patients with ulcerative colitis and their doctors by guiding treatment choices after initial therapies fail.

Plain English
This study looked at how effective and safe it is for patients with ulcerative colitis to switch to a second medication called JAK-inhibitors after not responding well to the first one. Out of 243 patients, about 48% achieved a good response without steroids after 12 weeks, but this dropped to 28% after a year. The findings show that if patients had problems with their first medication or were using steroids, they were less likely to benefit from the switch. Who this helps: This research benefits patients with ulcerative colitis who may need to change their medication.

Plain English
This study focused on the effectiveness and safety of the medication Risankizumab for patients with Crohn's disease. Researchers looked at 520 patients and found that 60.8% were symptom-free after 12 weeks, and by 52 weeks, 65.6% remained free of steroid use, with 37.5% showing improvement in their intestinal condition. These findings show that Risankizumab provides significant relief for patients who have had trouble with other treatments. Who this helps: This helps patients with Crohn's disease, particularly those who haven't responded well to other medications.

Plain English
This study focused on how different scoring systems can predict whether Crohn's disease will return after surgery. Researchers looked at over 170 patients and found that the Rutgeerts score was fairly effective, accurately predicting a clinical recurrence in 83% of cases but was less specific (57%). The study suggests that two newer scoring systems, the POCER index and the UEDA score, may provide better insights into the risk of disease return, particularly for inflammation at the surgical site. Who this helps: This research benefits patients with Crohn's disease by improving the prediction of disease recurrence after surgery, enabling better disease management.

Plain English
This study looked at elderly patients (age 60 and older) who were hospitalized for a flare-up of inflammatory bowel disease (IBD) and also had an infection called Clostridioides difficile (CDI). Researchers found that over the first year after discharge, 32% of CDI-positive patients and 33.1% of CDI-negative patients had complications related to their IBD, which shows that having CDI did not make a significant difference in health outcomes for these patients. The findings are important because they suggest that while elderly patients are at risk for complications after hospitalization, having a CDI infection doesn't worsen those risks. Who this helps: This benefits elderly patients with IBD and their healthcare providers as it informs care decisions and expectations.

Plain English
This study looked at different amounts of a contrast medium used in CT scans of the liver to see how well they improve image quality. They tested three groups of patients with dosages of 700 mg, 650 mg, and 600 mg iodine per kilogram of lean body weight. The group that received the highest dosage (700 mg) had the best image quality and liver enhancement, while the lower doses did not perform as well; for instance, it provided significantly higher contrast ratios and overall clarity in images. Who this helps: Patients undergoing liver scans.

Plain English
This study tested a new way to measure blood pressure accurately using wearable sensors instead of traditional cuffs. The researchers found that their method, called IMU-Track, significantly improved the accuracy of blood pressure readings taken from the arm, reducing errors in systolic measurements from an average of about 13.5 mmHg to just 5.9 mmHg when the arm was at varying heights. This improvement matters because it could allow for more accurate and convenient blood pressure monitoring without bulky equipment that limits movement. Who this helps: This benefits patients who need regular blood pressure checks and doctors who rely on accurate data for treatment decisions.

Plain English
This research paper looks at a new type of plastic called vitrimers, which can be recycled more easily than traditional thermosetting plastics. Vitrimers maintain strong and stable properties but can also be reshaped and reused when heated. This is important because it supports the recycling of materials, helping reduce waste in line with environmental goals. Who this helps: This benefits manufacturers and recyclers looking for sustainable material options.

Plain English
This study looked at inflammatory bowel diseases (IBDs) like Crohn's disease and ulcerative colitis, which are serious, long-lasting health issues. Researchers found that the immune system plays a big role in these illnesses, with specific immune cells causing inflammation, and that changes in gut bacteria and environmental factors, such as pollution and antibiotic use during pregnancy, increase the risk of developing IBDs. Understanding these factors is crucial because it can lead to better prevention and personalized treatment options for people affected by IBD. Who this helps: This helps patients with inflammatory bowel diseases and their doctors.

Plain English
This study focused on improving the calibration of tiny microphones known as MEMS microphones, which are sensitive to variations in sound pressure. Researchers developed a new method that combines computer simulations with practical adjustments to correct for inaccuracies caused by the microphones' design and placement. They found that this new method significantly reduced errors, especially for high-frequency sounds above 5 kHz, leading to more reliable measurements across a broad range of frequencies from 20 Hz to 20 kHz. Who this helps: This benefits engineers and technicians who work with sound measurement equipment, ensuring more accurate audio devices and systems.

Plain English
This study looked at hepatitis C (HCV) screening in Italy, focusing on people aged 55 to 85. Out of 13,042 tests conducted, 1.1% tested positive for HCV, with a higher rate in men and older individuals. The findings highlight significant differences in infection rates between genders and age, suggesting that tailored screening and treatment approaches are needed. Who this helps: This research benefits patients, particularly older adults and those at risk of hepatitis C.

Plain English
This study developed a sensor made from zinc oxide nanorods to detect leftover pesticides on tea leaves, specifically focusing on two common pesticides called quinalphos and thiamethoxam. The sensor accurately measures these pesticides by detecting changes in electrical resistance, showing strong and reliable results: it provides linear responses for quinalphos and unique patterns for thiamethoxam. This technology is important because it offers a quick and effective way to monitor pesticide levels, which helps ensure food safety and promote better farming practices. Who this helps: This benefits farmers, food safety regulators, and tea consumers.

Plain English
This study looked at how well two different ways of measuring cell movement in MRI scans could identify cancer in patients with multiple myeloma. Researchers found that using three measurements (b-values) in MRI scans produced slightly higher average readings for cancerous bone lesions (965.3) and healthy bone areas (588) compared to using just two measurements. This matters because better detection of cancerous lesions can help doctors make more accurate diagnoses and treatment decisions. Who this helps: This helps doctors and patients with multiple myeloma by improving cancer detection.

Plain English
This study looked at a new way to predict high-risk colon cancer using CT scans and genomic data to improve accuracy in staging the disease. Researchers analyzed 300 patients, where 262 were identified as high-risk. They found that their radiogenomics model performed significantly better than traditional methods, achieving an accuracy of 84%, compared to 65% with standard radiological interpretations. Who this helps: This benefits colon cancer patients by potentially leading to better treatment decisions.

Plain English
This study looked at contrast-enhanced mammography (CEM) using a higher concentration of iodine to see if it could improve breast cancer detection. They found that this method could identify cancerous lesions with 96% sensitivity and 87.5% specificity, which is significantly better than traditional methods, especially for women with dense breast tissue. This matters because it offers a more effective way to detect aggressive cancers while using less contrast material. Who this helps: Patients, especially women with dense breasts, benefit from improved early cancer detection.

Plain English
This study looked at the role of a protein called interleukin-23 (IL-23) in ulcerative colitis (UC), a type of inflammatory bowel disease. Three new drugs targeting IL-23—mirikizumab, risankizumab, and guselkumab—were tested and found to be effective in reducing symptoms like bowel urgency, with low side effects reported. Understanding how to best use these medications could greatly improve treatment options for patients with UC. Who this helps: This helps patients with ulcerative colitis by providing new treatment options.

Plain English
This study examined 1,000 food samples to see how common a type of antibiotic-resistant bacteria, called ESBL-producing strains, are in our food. They found these bacteria in 2.8% of the samples, with the highest rate of 10% in raw meat. In total, they identified 31 strains that were resistant to multiple antibiotics, indicating a serious food safety concern that could affect public health. Who this helps: This information is crucial for patients and health officials working to improve food safety.

Plain English
This research paper discusses how transparent wood (TW) is made and improved. Researchers explored what affects its clarity, including the type of wood used, methods to remove substances that make it less clear, and the polymers added to enhance its transparency. They found that achieving a glass-like clarity is possible but still faces challenges, particularly in ensuring the materials work well together to let light pass through without interruptions. Who this helps: This benefits manufacturers and builders looking for eco-friendly materials that combine beauty and functionality.

Plain English
This study looked at how doctors who treat inflammatory bowel disease (IBD) manage patients with liver enzyme abnormalities. It found that 97% of doctors regularly check liver enzymes, but there are different practices on when to investigate further—over 70% did extra testing when enzymes were abnormal, but the reasons and thresholds for doing so varied widely. Many doctors feel they need more training and clearer guidelines for handling these liver issues, as a majority (62%) cited a lack of specific rules as a key challenge. Who this helps: This helps patients with IBD who may experience liver issues, as it highlights the need for better management and care.

Plain English
This study looked at how well a medication called tofacitinib (TOFA) works for treating joint pain related to ulcerative colitis (a bowel disease). Out of 44 patients who completed the study, 52.3% showed improvement after 8 weeks, and 59.1% maintained that improvement after a year, especially those with peripheral joint pain. This is important because it provides evidence that TOFA can effectively help patients with ulcerative colitis who also have difficult-to-treat joint pain. Who this helps: Patients with ulcerative colitis and related joint pain issues.

Plain English
This study looked at what happens when patients with inflammatory bowel disease (IBD) switch from one type of biosimilar medication to another for reasons not related to their health (called nonmedical switching). Researchers followed two groups of patients for a year after they switched medications, finding that 84% of patients continued their treatment with one biosimilar and 79% with another. Overall, the switch did not lead to significant changes in how well the treatments worked, the safety of the medications, or patients' mental well-being. Who this helps: This benefits patients with IBD who may be switched to different biosimilars without compromising their treatment.

Plain English
This study examined how mental health and gut bacteria influence the progression of ulcerative colitis (UC) over five years. It found that UC patients who had failed biological therapies had higher levels of certain harmful gut bacteria and lower levels of beneficial ones, suggesting a connection between gut health and treatment effectiveness. Additionally, patients with severe psychological distress experienced worse outcomes, such as needing surgery or hospitalization. Who this helps: This information can support both patients and doctors in understanding the importance of mental health and gut health in managing ulcerative colitis.

Plain English
This study looked at patients with Crohn's disease (CD) to find out what factors might predict the development of short bowel syndrome (SBS), a serious condition where the intestine is too short to absorb enough nutrients. Out of 232 patients, 18 developed SBS, and two key factors were identified: the longer a person has had Crohn's disease, the higher their risk of developing SBS (increase by 8% for every extra year), and having a specific type of gastrointestinal involvement increased the risk significantly (20 times more likely). Understanding these factors is important because it can help doctors monitor patients more closely and potentially prevent the development of SBS. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study looked at the risks of blood clots and heart problems in patients with ulcerative colitis who started advanced treatments. Researchers followed 300 patients for about 27 months and found low rates of these events: only four patients experienced issues, including two blood clots and two heart-related problems. This matters because it indicates that patients with ulcerative colitis using advanced therapies generally have low risks of these severe complications, easing concerns about their treatments. Who this helps: This helps patients with ulcerative colitis and their doctors make informed treatment decisions.

Plain English
This study examined the effectiveness and safety of the drug filgotinib for treating ulcerative colitis (UC) in patients who had already tried other treatments. Out of 102 patients followed for about six months, 46% achieved clinical remission by the end of the study, and those who started filgotinib first had a higher success rate compared to those on second or third lines of therapy. This research is important as it shows that using filgotinib early in treatment can lead to better outcomes with relatively few adverse effects. Who this helps: This benefits patients with ulcerative colitis, particularly those looking for effective treatment options.

Plain English
This study looked at how using ultrasound during surgery for Crohn's disease could help surgeons remove affected parts of the small intestine more effectively. Researchers found that using this method led to a significant reduction in the rate of positive margins—where cancer cells are found at the edges of the surgically removed tissue—going from 48.1% in the traditional approach to 18.5% with ultrasound use. This matters because reducing positive margins can decrease the chances of the disease returning after surgery. Who this helps: This aids patients with Crohn's disease by improving surgical outcomes.

Plain English
This study looked at how well different medications work for patients with perianal Crohn's disease who did not respond to initial treatment with anti-TNF drugs. Researchers found that 79.5% of patients treated with ustekinumab (UST) as a second-line therapy experienced improvement, compared to only 58.9% with vedolizumab (VDZ) and 48.7% with another anti-TNF. This indicates that ustekinumab is potentially more effective than its alternatives for patients who have already failed other treatments. Who this helps: This information benefits patients with perianal Crohn's disease and their healthcare providers by guiding treatment choices.

Plain English
This study looked at the effectiveness and safety of Upadacitinib (UPA) in treating patients with ulcerative colitis who did not respond to other treatments. Among 202 patients, 45.5% achieved clinical remission at 8 weeks, and by the end of the study, 60.2% were in remission, with 84.6% showing healing in their intestinal lining. The research confirms that UPA is a valuable option for patients with difficult-to-treat ulcerative colitis, with a low rate of serious side effects. Who this helps: Patients with ulcerative colitis who have not had success with other treatments.

Plain English
This study looked at what happens to patients with inflammatory bowel disease (IBD) when they stop using two types of treatment: anti-TNF drugs and non-anti-TNF drugs like vedolizumab and ustekinumab. Out of 223 patients, 72% experienced a flare-up of their condition within a year after stopping treatment, with those who stopped non-anti-TNF drugs having a higher relapse rate of 80% compared to 65% for anti-TNF users. These findings show that the decision to stop treatment should be personalized, especially since longer treatment before reaching remission can lower the risk of relapse. Who this helps: Patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at the occurrence of acute pancreatitis (AP) in patients with inflammatory bowel disease (IBD) across Europe over ten years. It found that about 0.58% of IBD patients had AP, with most cases being mild, and drugs like azathioprine were the main cause in over half of the patients. Understanding these findings is important because they help identify which IBD patients are at risk for pancreatitis and how to manage their treatment more effectively. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at the effectiveness and safety of the drug vedolizumab for patients with inflammatory bowel disease (IBD) over two years. Researchers found that about 31.6% of patients with Crohn’s disease and 39.7% with ulcerative colitis experienced clinical remission, and there were very few adverse events, averaging 0.14 per patient per year. Understanding who is more likely to benefit from this treatment helps improve patient care. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at fecal microbiota transplantation (FMT) as a treatment for ulcerative colitis, a type of inflammatory bowel disease. Experts found that while FMT has shown promise in helping patients with this condition, there is still a need for more thorough clinical trials to properly assess its effectiveness. They highlighted the importance of creating standardized methods for future studies, which could lead to better treatment options and improved health outcomes for patients. Who this helps: This helps patients with ulcerative colitis seeking new treatment options.

Plain English
Researchers adapted European quality care standards for inflammatory bowel disease (IBD) to better fit Italy's healthcare system. They started with 101 statements from the European Crohn's Colitis Organisation and created 112 tailored criteria for Italian care, confirming 80 of the original statements while adding 12 new ones. This is important because it aims to improve the consistency and quality of IBD treatment in Italy, which can lead to better patient outcomes. Who this helps: Patients with inflammatory bowel disease in Italy.

Plain English
The study looked at how the care given to Crohn's disease patients after surgery has changed over the last 40 years and whether those changes affected how often patients needed more surgery. Researchers followed 657 patients who had surgery between 1980 and 2020, finding that the use of immunosuppressants and anti-TNF treatments increased significantly over time, but this didn't lead to lower rates of needing additional surgeries over the long term. This matters because it highlights that even with more advanced treatments available, they have had little impact on long-term surgery rates for Crohn's disease. Who this helps: This helps doctors and Crohn's disease patients by informing them about the effectiveness of current post-surgery treatment strategies.

Plain English
This study looked at how a father's gut bacteria before conception can affect the health of his offspring. Researchers found that when fathers had disrupted gut bacteria due to things like certain antibiotics, their babies were more likely to be born with low birth weight, grow poorly, or even die prematurely. Correcting the father's gut bacteria before conception helped improve these outcomes, highlighting the importance of a healthy gut for future generations. Who this helps: This helps expectant fathers and their future children.

Plain English
This study looked at patients who developed colitis after receiving immune checkpoint inhibitors (ICIs), a type of cancer treatment. Among 96 patients followed for a year, almost half (47.7%) achieved remission from their symptoms after 12 months, but nearly 80% had to stop their cancer treatment because of colitis. This is important because patients with a type of colitis resembling Crohn's disease had worse outcomes, suggesting they may need more intense treatment earlier to improve their chances of recovery. Who this helps: This helps patients experiencing colitis from cancer treatment and their doctors in managing their care.

Plain English
Researchers studied the use of special bioresorbable fibers made from phosphate glass for a specific type of light analysis known as time-domain diffuse optical spectroscopy (TD-DOS), which operates in the short-wave infrared range of 950-1600 nm. They found that these fibers can effectively identify important biological markers like water and fat in tissues, and when tested on samples like pig muscle and fat, the results matched well with measurements taken using standard fibers. This is significant because it means that doctors could monitor treatments by analyzing deeper tissues without needing to remove these fibers from the body. Who this helps: This helps patients undergoing treatment by allowing better monitoring of their condition.

Plain English
This study looked at how common short bowel syndrome (SBS) and chronic intestinal failure (CIF) are in patients with Crohn's disease in Italy and how well they are being treated. It found that about 1% of Crohn's patients with a small intestine issue have CIF, and this number is higher in academic hospitals (2%) compared to other centers. Unfortunately, many hospitals are not properly measuring patients' small intestines or assessing their nutritional needs, and only a small number are using a medication called teduglutide, which has been effective for more than half of patients treated. Who this helps: This research benefits doctors and healthcare providers managing Crohn's disease patients.

Plain English
This study looked at using cork in building materials to create more environmentally friendly construction practices. Researchers tested different mixtures of mortar with up to 3% cork, finding that the mixes not only had good strength but also improved water absorption and adhesion to brick surfaces. Specifically, they found that rougher surfaces on bricks helped the cork-reinforced mortar stick better, making it a strong option for sustainable building. Who this helps: This benefits builders, construction companies, and environmentally-conscious developers looking for greener building materials.

Plain English
This study looked at how imaging techniques, like CT and MRI, help in diagnosing and managing Crohn's disease, which causes inflammation in the bowel. It found that MRI is particularly effective because it can provide detailed information about the disease without using harmful radiation, making it better for assessing how active the disease is. Understanding these imaging options is important because they can help doctors make better decisions about treatment and monitor the disease over time. Who this helps: This benefits patients with Crohn's disease and their doctors.

Plain English
This study looked at how well the drug ustekinumab (UST) works for patients with Crohn's disease over a long period. Among 562 patients, 80% were in clinical remission after two years, and an impressive 95.4% were in remission after one year of treatment. Only a small number needed surgery (2.1%) or faced other treatment adjustments, showing that UST is generally safe and effective for long-term use. Who this helps: This benefits patients with moderate to severe Crohn's disease seeking effective long-term treatment options.

Plain English
This study looked at a new treatment for complex perianal fistulas in patients with inflammatory bowel disease (IBD). Out of 12 procedures performed on 10 patients, 83% showed clinical healing, while 50% showed healing on imaging after 6 months. This is important because current treatment options are often ineffective, and many patients continue to suffer from these painful and debilitating conditions. Who this helps: Patients with inflammatory bowel disease experiencing complex perianal fistulas.

Plain English
This study looked at factors that contribute to the likelihood of Crohn's disease returning after surgery to remove part of the intestines. Out of 63 patients, 24 (38%) experienced a return of the disease within two years. Key findings showed that the older a patient was when they had the surgery, and specific characteristics of their disease, such as the location and extent of the affected bowel, increased the chances of recurrence. Who this helps: This research benefits patients with Crohn's disease and their doctors by identifying risks that can inform treatment decisions.

Plain English
This study looked at patients with ulcerative colitis who appeared to have healed mucosal tissue but still had signs of ongoing disease activity in their tissue samples. Out of 100 patients, only 2 showed no remaining signs of disease. The research found that certain conditions in the tissue, like basal plasmacytosis and surface irregularity, were linked to a higher chance of the disease coming back; specifically, patients with these features were 2.98 to 4.50 times more likely to relapse. Who this helps: This helps patients with ulcerative colitis and their doctors by identifying risks for disease reactivation.